This event has passed. Watch the recording →

The US Food and Drug Administration (FDA) is currently reviewing the first-ever application for an over-the-counter (OTC) birth control pill, a progestin-only product called Opill. In order for a birth control pill to be approved for OTC status, the FDA must deem it safe, effective, and appropriate for people to use without the involvement of a health care provider. Decades of research show that birth control pills are safe and effective. But what does the most recent data on progestin-only pills (POPs) tell us about people’s experience using the product and what do providers think about the potential impact of an OTC pill on their patient’s ability to access birth control and make autonomous decisions about their reproductive health? 

Join Free the Pill for a webinar featuring an esteemed panel of experts who will discuss the most recent research on people’s experiences using POPs as well as clinical perspectives on the importance of expanding equitable access to birth control pills now, more than ever. This webinar will present findings from two recent studies published by researchers at Ibis Reproductive Health—one on the experiences of POP users who received a prescription for POPs and the other on the experiences of people who used a POP in an OTC-like environment during a trial. Presentations will be followed by a panel discussion and Q&A with the audience.